Header Logo

Connection

Mark Lang to Antigens, CD1d

This is a "connection" page, showing publications Mark Lang has written about Antigens, CD1d.
Connection Strength

3.826
  1. CD1d-dependent CLL progression? Blood. 2017 06 29; 129(26):3398-3399.
    View in: PubMed
    Score: 0.566
  2. CD1d-dependent expansion of NKT follicular helper cells in vivo and in vitro is a product of cellular proliferation and differentiation. Int Immunol. 2015 May; 27(5):253-63.
    View in: PubMed
    Score: 0.480
  3. The importance of B cell CD1d expression for humoral immunity. Expert Rev Vaccines. 2014 Nov; 13(11):1275-8.
    View in: PubMed
    Score: 0.459
  4. Differential contribution of dendritic cell CD1d to NKT cell-enhanced humoral immunity and CD8+ T cell activation. J Leukoc Biol. 2012 May; 91(5):783-90.
    View in: PubMed
    Score: 0.390
  5. Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory. Int Immunol. 2011 Apr; 23(4):251-60.
    View in: PubMed
    Score: 0.365
  6. CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies. Infect Immun. 2010 Apr; 78(4):1610-7.
    View in: PubMed
    Score: 0.338
  7. Bacillus anthracis lethal toxin disrupts TCR signaling in CD1d-restricted NKT cells leading to functional anergy. PLoS Pathog. 2009 Sep; 5(9):e1000588.
    View in: PubMed
    Score: 0.330
  8. Coordination between T helper cells, iNKT cells, and their follicular helper subsets in the humoral immune response against Clostridium difficile toxin B. J Leukoc Biol. 2017 02; 101(2):567-576.
    View in: PubMed
    Score: 0.133
  9. BAFF- and APRIL-dependent maintenance of antibody titers after immunization with T-dependent antigen and CD1d-binding ligand. J Immunol. 2013 Aug 01; 191(3):1154-63.
    View in: PubMed
    Score: 0.107
  10. Type II NKT cells facilitate Alum-sensing and humoral immunity. J Leukoc Biol. 2012 Oct; 92(4):883-93.
    View in: PubMed
    Score: 0.100
  11. CD40L-null NKT cells provide B cell help for specific antibody responses. Vaccine. 2011 Nov 15; 29(49):9132-6.
    View in: PubMed
    Score: 0.095
  12. Regulation of anthrax toxin-specific antibody titers by natural killer T cell-derived IL-4 and IFN?. PLoS One. 2011; 6(8):e23817.
    View in: PubMed
    Score: 0.094
  13. Glycolipid-activated NKT cells support the induction of persistent plasma cell responses and antibody titers. Eur J Immunol. 2008 Apr; 38(4):1001-11.
    View in: PubMed
    Score: 0.075
  14. Requirement for CD1d expression by B cells to stimulate NKT cell-enhanced antibody production. Blood. 2008 Feb 15; 111(4):2158-62.
    View in: PubMed
    Score: 0.073
  15. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner. Immunology. 2006 Sep; 119(1):116-25.
    View in: PubMed
    Score: 0.066
  16. BCR targeting of biotin-{alpha}-galactosylceramide leads to enhanced presentation on CD1d and requires transport of BCR to CD1d-containing endocytic compartments. Int Immunol. 2005 Jul; 17(7):899-908.
    View in: PubMed
    Score: 0.061
  17. Presentation of alpha-galactosylceramide by murine CD1d to natural killer T cells is facilitated by plasma membrane glycolipid rafts. Immunology. 2004 Jul; 112(3):386-96.
    View in: PubMed
    Score: 0.057
  18. Loss of natural killer T cells promotes pancreatic cancer in LSL-KrasG12D/+ mice. Immunology. 2017 09; 152(1):36-51.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.